SOPHARMA AD - Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. SFA_89t_30102024_espi.pdfNotification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 117 / 2024

Date of issue: 2024-10-30

Short name of the issuer

SOPHARMA AD

Subject

Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria October 30, 2024 - According to the requirements of Art. 89t of the LPOS, "Sopharma" AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies all interested parties that the Company on the basis of Art. 89t of the Law on the Public Offering of Securities, in connection with the decision of the Board of Directors of "SOPHARMA" AD dated October 14, 2024 and on the basis of Art. 195 and 196 of the Commercial Law (CL), Art. 113, para. 2, it. 2 of the LPOS and Art. 25 of the Company's Articles of Association and based on item 12 of the Prospectus for the initial public offering of warrants, confirmed by FSC Decision No. 804 – E/04.11.2021, due to the lack of a request to convene a meeting of warrant holders before the maturity of the warrant issue has launched a final capital increase procedure by issuing up to 623,779 ordinary, registered, dematerialized shares, provided that the shares from the increase are subscribed by the holders of warrants from issue ISIN BG9200001212, in accordance with the terms and conditions described in the Prospectus for the public offering of warrants, confirmed with FSC Decision No. 804-E/04.11.2021.

Annexes

File Description

SFA_89t_30102024_espi.pdfSFA_89t_30102024_espi.pdf Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2024-10-30 Ognian Donev Executive director